Dexmedetomidine Injection, Solution
Product Images NDC 66794-233

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 66794-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Partition Details: This document describes a partition type called "oneyeamt ype" that is packed in three Vel o os and made of 300 5% Cybor XL Board. The dimensions of the partition are 8x8x33 1 mm (LAWH). The document also contains information about Dexmedstomidine Injection, USP and Dexmedotomidine Injection, USP. The text includes some unintelligible characters and unrelated product names such as "novaplust BRI".*

FDA Label Image

Label (Label)

This is a medication description for Dexmedetomidine injection, USP, provided in a 2 mL single-dose vial with NDC 66794.233.02. Each 2 mL vial contains 200 micrograms of the active ingredient, which corresponds to 100 micrograms per milliliter. The medication is intended for IV use only and must be diluted before administration. It is manufactured by Piramal Critical Care located in Bethlehem, PA, USA. The rest of the text is not legible.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.